SOMISETRON (Ondansetron Injection IP)
Reliable Antiemetic Solution for Nausea & Vomiting Control
SOMISETRON contains Ondansetron, a highly effective 5-HT3 receptor antagonist used for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and surgical procedures. It provides rapid and dependable relief in clinical settings.
Key Features & Benefits
- Selective 5-HT3 receptor antagonist with proven efficacy
- Effectively controls acute nausea and vomiting
- Rapid onset of action via IV/IM administration
- Facilitates better patient comfort and recovery
- Does not cause extrapyramidal side effects (EPS)
- Well tolerated with an established clinical safety profile
Indications
SOMISETRON is indicated for the management of:
- Chemotherapy-induced nausea and vomiting (CINV)
- Radiotherapy-induced nausea and vomiting
- Post-operative nausea and vomiting (PONV)
- Acute gastroenteritis-related vomiting
Dosage & Administration
- Administered via Intravenous (IV) or Intramuscular (IM) route
- Typically given before chemotherapy or surgery as prescribed
- Dosage should be as directed by a healthcare professional
Pharmacological Advantages
- Works by blocking serotonin (5-HT3) receptors, preventing nausea reflex (MedlinePlus)
- Provides effective control of vomiting caused by chemotherapy and surgery (Mayo Clinic)
- Rapid action ensures quick symptom relief
- Suitable for use in hospital and emergency care settings
Safety & Tolerability
- Generally well tolerated when used as prescribed
- Minimal risk of neurological side effects
- Established safety in both adult and pediatric use under supervision
Why Choose SOMISETRON?
- Trusted antiemetic for critical care and oncology support
- Fast and reliable relief from nausea and vomiting
- Ideal for hospital and clinical use
Packaging
- Available in injectable ampoules (e.g., 4 mg / 2 ml)
Tagline
A Name of Relief in Nausea & Vomiting